Biote vs Kamada
Biote and Kamada are similar in size: $192m and $180m of revenue in their latest fiscal years. Kamada grew faster (12.1% against -2.5%). Biote kept more of each dollar of sales as profit: a net margin of 14.1% against 11.2%.
| Latest fiscal year | BioteBTMD, 2025 | KamadaKMDA, 2025 |
|---|---|---|
| Revenue | $192m | $180m |
| Revenue growth | -2.5% | 12.1% |
| Net income | $27.0m | $20.2m |
| Operating margin | 18.5% | 14.5% |
| Net margin | 14.1% | 11.2% |
| Return on equity | — | 7.6% |
| Free cash flow | $30.2m | — |
| Cash | $24.1m | $75.5m |
| Total debt | $103m | $9.9m |
| Debt to equity | — | 3.7% |
| Dividend per share | — | — |
| Dividend yield | 3.6% | 2.7% |
| Share buybacks | $3.4m | — |
| Employees | 223 | — |
| Market value | $33.2m | $418m |
| Price vs our value range | Below our value range | Below our value range |
| Moat score | 33 (Weak) | — |
| Insider trades, 12 months | 2 buys, 0 sales | 0 buys, 4 sales |